Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2026-04-19 @ 8:29 PM
Study NCT ID:
NCT01374503
Status:
TERMINATED
Last Update Posted:
2012-04-17
First Post:
2011-06-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4
Sponsor:
Ablynx, a Sanofi company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ALX-0651-1.1/11
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None